Mylan CEO Heather Bresch speaks to CNBC's Meg Tirrell about the future of EpiPen pricing under President-elect Donald Trump as he pushes to bring drug prices down.
Mylan CEO Heather Bresch speaks to CNBC's Meg Tirrell about the future of EpiPen pricing.
CNBC's Meg Tirrell speaks with Express Scripts President & CEO Tim Wentworth on pharmacy benefit managers and drug pricing pressure.
Pharmaceutical industry’s middlemen face a greater scrutiny next year, according to Breakingviews.
This is a stock picker's market, says Bob Doll, Nuveen Asset Management, providing his top stock plays. I love the airlines, says Doll.
CNBC's Meg Tirrell reports on the launch of Mylan's "authorized generic" version of their EpiPen.
Some of the names on the move ahead of the open.
John Fichthorn of Dialectic Capital discusses his latest short positions, including AutoNation, Carmax and more.
Earlier Thursday, Left's Citron Research called Express Scripts the "Philidor of the pharma industry."
Citron Research's Thursday afternoon tweet sent shares of Express Scripts tanking, and someone appeared ideally positioned for the move.
Short-seller Andrew Left, Citron Research, discusses his tweet directing Donald Trump's attention towards Express Scripts, and his other shorts in the pharmaceutical space.
Short-seller Andrew Left, Citron Research, explains why Express Scripts is the "Philidor of the pharma industry," referring to Philidor Rx Services' alleged misconduct with Valeant Pharmaceuticals.
Shares of Express Scripts plunge following short-seller Andrew Left's series of tweets taking aim at the company. CNBC's Meg Tirrell reports.
Citron Research tweeted that Express Scripts is "Philidor of the pharma industry," referring to Philidor Rx Services' alleged misconduct.
Shares of Express Scripts fall sharply on a series of tweets from Citron Research. CNBC's Dominic Chu reports.
CNBC's Meg Tirrell speaks with Express Scripts chief medical officer Dr. Steve Miller about the role of pharmacy benefits managers in drug pricing.
In the likely repeal of the Affordable Care Act, these health-care stocks should perform well, according to some analysts.
The “Fast Money Halftime Report” traders and Kourtney Gibson, Loop Capital president, share their takes on the healthcare sector.
John Fichthorn, Dialectic Capital co-founder, discusses why he is short Express Scripts.
The "Fast Money" traders share their first moves for the market open.